Hematology

Cell Counts

Manual and Automated Cell Counts, Reticulocytes, and Body-Fluid Hematology

A cell count is only as trustworthy as its method. Manual hemacytometer counting, automated impedance, optical scatter, and fluorescence counting, and point-of-care instruments each fail in characteristic ways, and the laboratory’s job is to know which failure a given specimen or result pattern risks. Reticulocyte studies measure marrow response, and hematology performs body-fluid counts; corrections and cross-checks separate a true result from an artifact.

Manual chamber counts

Every manual blood cell count, whether white cells, red cells, platelets, or a body-fluid nucleated cell count, rests on one relationship:

Cells/µL = (cells counted × dilution factor) ÷ (area counted, mm2 × chamber depth, mm)

The counting chamber, an improved Neubauer ruling machined to 0.1 mm under the coverslip, divides its ruled area into nine 1-mm2 squares. The four corner squares, each subdivided into sixteen smaller squares, serve white-cell and body-fluid counts; the central square, subdivided into twenty-five smaller squares, serves red-cell and platelet counts. Because 1 mm3 equals 1 µL, a cells/µL result multiplies by 106 for a per-liter expression: ×109/L for white cells and platelets, ×1012/L for red cells. Chamber geometry, volume arithmetic, and worked duplicates live in the Manual Cell-Counting Calculations page.

CountDiluentDilutionOpticsArea counted
WBC1% ammonium oxalate, 3% acetic acid, or 1% hydrochloric acid (lyses erythrocytes)1:2010×4 mm2 (four corner squares)
WBC, markedly elevatedSame1:10010×Entire 9-mm2 ruling, both sides
RBCIsotonic saline1:10040×0.2 mm2 (five small squares of the center square)
Platelet1% ammonium oxalate1:10040×, phase contrast1 mm2 (entire center square)

One boundary rule keeps stray cells from being counted twice. A cell touching the top or left line of a square is counted; a cell touching the bottom or right line is not. The same rule governs reticulocyte counts made with a Miller disc.

Manual white-cell count. Well-mixed EDTA or skin-puncture blood is diluted 1:20 in a diluent that lyses nonnucleated erythrocytes, which would otherwise be indistinguishable from small lymphocytes.1 After 10 minutes for lysis, with counting completed within 3 hours of dilution, both chamber sides are charged, rested 10 minutes in a humidified chamber, and the four corner squares on each side are counted at 100× total magnification. Side-to-side totals should agree within 10%; a wider gap means uneven charging and a repeated preparation.

Worked example. One chamber side totals 148 cells across the four corner squares and the other side totals 152, an acceptable difference. Averaging gives 150:

WBC = (150 × 20) ÷ (4 mm2 × 0.1 mm) = 3000 ÷ 0.4 = 7,500/µL, or 7.5 × 109/L

For markedly elevated counts, a 1:100 dilution counted over the full 9-mm2 ruling on both sides improves precision, because counting more cells reduces the Poisson sampling error at a given total.

Nucleated red-cell correction. The lytic diluent leaves nucleated red blood cells (NRBCs) intact, so they count as white cells and falsely raise the result. The conventional trigger, and the one the ASCP BOC applies for examination purposes, is more than 10 NRBCs per 100 white cells; a laboratory may set a lower trigger in its own procedure. Once the threshold is met:

Corrected WBC = uncorrected WBC × 100 ÷ (NRBCs per 100 WBCs + 100)

A count of 15.0 × 109/L with 25 NRBCs per 100 white cells corrects to 15.0 × 100 ÷ 125 = 12.0 × 109/L, and the corrected value is reported explicitly. Automated counts on platforms that do not enumerate and subtract NRBCs online receive the same correction.

Common errors include chamber or coverslip contamination, incomplete erythrocyte lysis, premature reading, and improper charging. A very low count warrants counting a larger validated area to reduce sampling error, and a film-based white-cell estimate cross-checks the chamber result.

Manual platelet count. Platelets clump readily and adhere to glass, so the specimen demands careful technique. EDTA blood is diluted 1:100 in 1% ammonium oxalate, which lyses erythrocytes and leaves platelets intact, and counted with phase-contrast optics after a 15-minute settling period. Platelets appear round to oval, 2 to 4 µm, with a faint purple sheen that distinguishes them from refractile debris. All 25 small squares of the center square are counted on each side, with the same 10% agreement rule.

Worked example. Duplicate chamber sides average 185 platelets in the 1-mm2 center square:

Platelet count = (185 × 100) ÷ (1 mm2 × 0.1 mm) = 18,500 ÷ 0.1 = 185,000/µL, or 185 × 109/L

Poor mixing or collection causes in vitro clumping; when redilution fails to resolve it, the specimen is redrawn, and skin-puncture collection makes clumping worse. Dirty pipettes, chambers, or diluent add error. A count far outside the expected range prompts a dilution change, 1:20 when fewer than 50 platelets per side are visible and 1:200 when more than 500 appear, with the matching dilution factor applied. EDTA-dependent platelet satellitosis, an in vitro antibody artifact in which platelets rosette around neutrophils, falsely lowers the count; the specimen is redrawn into sodium citrate and the result multiplied by 1.1 to correct for the citrate dilution.

Electrical impedance, the Coulter principle. Cells suspended in a conductive diluent cross a narrow aperture between electrodes carrying a constant low-frequency current.1 Each cell, essentially a nonconducting particle, momentarily raises the resistance between the electrodes and produces a voltage pulse. The pulse train carries two measurements: the number of pulses tracks the cell count, and the height of each pulse tracks the cell volume. Pulses sort by height into a volume histogram, thresholds bracket each population of interest, and the reported count is the pulses between them.

Four physical artifacts distort the raw signal unless the instrument corrects for them:

  • Aperture fouling. Protein buildup narrows the orifice, slows transit, and produces falsely low counts with falsely elevated volumes. Modern analyzers apply burn circuits and automated cleaning cycles.
  • Coincidence. Two cells crossing together generate one oversized pulse, lowering the count and inflating the apparent volume. Because coincidence probability is a predictable function of cell concentration and aperture volume, the analyzer applies a statistical correction.
  • Off-center passage and reduced deformability. A cell crossing off-axis, or a poorly deformable red cell, yields an altered pulse height. This biases impedance-derived volumes and histograms while leaving photometric hemoglobin and calculated MCH untouched.
  • Recirculation. Cells swirling back through the sensing zone add spurious pulses; a sweep-flow backwash clears the zone between passes.

Hydrodynamic focusing injects the sample inside a sheath fluid so cells cross the aperture centered, attenuating both off-center passage and coincidence.

Combined DC/RF measurement. Pairing direct-current impedance with a high-frequency radiofrequency current across the same aperture adds a second measurement of each cell. Direct-current pulse height still tracks total volume, while radiofrequency attenuation reflects internal composition: nuclear density, nucleus-to-cytoplasm ratio, cytoplasmic granularity. Two cells of equal volume but different internal structure separate, and plotting the two dimensions produces a scatterplot where each leukocyte population forms its own cluster. A five-part differential, neutrophils, lymphocytes, monocytes, eosinophils, and basophils, becomes possible without morphologic examination.

Optical light scatter. In a flow-cytometric optical channel, hydrodynamically focused cells cross a focused monochromatic beam inside a flow cell. Fixed-angle photodetectors capture the scattered light, and each collection angle reports a different property.

Scatter angleChiefly reflectsUnderlying process
Forward, low angle (~0°)Cell volumeDiffraction
Orthogonal, side scatter (90°)Internal complexity: granules, nuclear lobulationRefraction and reflection
Forward, intermediate angleCombination of volume and refractive index or complexityMixed

Manufacturers combine angles differently, some pairing scatter with absorption or with impedance volume, and read the resulting two-dimensional cytograms by cluster location and density.

Fluorescence. A fluorescent nucleic-acid-binding dye contributes a chemically specific third axis, because fluorescence intensity tracks residual RNA and DNA content. Immature and nucleated cells fluoresce more brightly than mature anucleate cells. Combined with forward and side scatter, fluorescence separates populations that overlap physically: an immature granulocyte from a mature neutrophil, a nucleated red cell from a small lymphocyte, a reticulocyte from a mature erythrocyte. It underlies automated differentials, automated NRBC enumeration, and fluorescent reticulocyte and platelet counting on current analyzers.

Spurious results and analyzer interference

ConditionParameters affectedMechanismInstrument clueCorrection
Cold agglutininsRBC↓, MCV↑ (often above 130 fL), MCHC↑ (often above 40 g/dL)Red-cell autoagglutinationDual population or right-shifted red-cell histogramWarm specimen to 37 °C and rerun
Lipemia, icterusHGB↑, MCH↑Turbidity inflates spectrophotometric hemoglobinRule of three fails, 3 × HGB differs from HCT by more than 3Plasma replacement, or platform back-calculation of hemoglobin
In vitro hemolysisRBC↓, HCT↓Erythrocytes lysed and uncountedRule of three failsRecollect
Lysis-resistant red cells (Hb S, Hb C)WBC↑, HGB↑Sickled and target cells resist the lytic reagent and count as white cellsInterference at the noise-WBC thresholdManual dilution with extended lysis time
Microcytes, schistocytesRBC↓, PLT↑Fragments fall below the red-cell threshold or into the platelet size rangeLeft-shifted red-cell histogram, abnormal platelet histogramFilm review
NRBCs, megakaryocyte fragmentsWBC↑ when the platform includes themCounted as white cells when not separately enumeratedNRBC flag, interference at the noise-lymphocyte thresholdEnumerate and correct per the platform’s validated method
Platelet clumpsPLT↓, WBC↑Clumps count as leukocytesClump flagRedraw in sodium citrate, multiply by 1.1
WBC above 100 × 109/LHGB↑, RBC↑Turbid white-cell lysate interferes with hemoglobin; white cells miscounted with red cellsRule of three fails; count may exceed linearityManual hematocrit and hemoglobin, dilution for the white count
Leukemia, especially after chemotherapyWBC↓, PLT↑Fragile white-cell fragments count as plateletsCount inconsistent with historyFilm review; phase-contrast or CD61-based platelet count
Aged specimenMCV↑, MPV↑, PLT↓; unreliable differentialRed-cell swelling, platelet swelling and degeneration from prolonged EDTA exposureAbnormal white-cell clusteringEnforce specimen stability and rejection limits

Some platforms back-calculate corrected hemoglobin from directly measured cellular hemoglobin concentration, which reduces the need for manual plasma replacement in lipemic specimens.

The reticulocyte is the terminal immature erythrocyte, spending roughly 2 days in the marrow and 1 day in peripheral blood before shedding its residual ribosomal RNA.1,2 Because reticulocyte output tracks marrow erythropoietic activity in real time, the count separates hypoproliferative anemia from anemia with an appropriate marrow response.

Manual method. EDTA blood is mixed with an equal volume of new methylene blue, incubated 3 to 10 minutes at room temperature, and made into a wedge film. A cell qualifies as a reticulocyte when it contains two or more discrete blue-staining granulofilamentous particles. Using the edge rule, 1,000 erythrocytes are counted under oil immersion with reticulocytes tallied separately, a reticulocyte entering both totals:

Reticulocytes (%) = (reticulocytes counted ÷ 1,000) × 100

Worked example. Thirty-one reticulocytes among 1,000 erythrocytes give 3.1%.

The Miller disc reduces the workload. Its reticle carries two squares, the smaller exactly one ninth the area of the larger: erythrocytes are counted in the small square and reticulocytes in the large square.

Reticulocytes (%) = [reticulocytes in large square ÷ (erythrocytes in small square × 9)] × 100

Worked example. Thirty reticulocytes in the large square and 120 erythrocytes in the small square give 30 ÷ (120 × 9) × 100 = 2.78%. The small-square erythrocyte tally must still be large enough that the equivalent large-square population meets the laboratory’s minimum cell count.

Sources of error. The incubated blood-stain mixture must be remixed immediately before the film, because reticulocytes rise in a standing mixture. Refractile drying artifact can mimic reticular material. Other supravitally stained inclusions must stay out of the tally: Heinz bodies, precipitated denatured hemoglobin, round to oval and membrane-associated; Howell-Jolly bodies, solitary round nuclear remnants; and Pappenheimer bodies, clustered siderotic granules confirmable with Prussian blue.

Absolute reticulocyte count. The percentage translates into a true concentration:

ARC = (reticulocyte % × RBC count) ÷ 100

Worked example. A 3.0% reticulocyte count with a 3.50 × 1012/L erythrocyte count gives (3.0 × 3.50 × 1012) ÷ 100 = 105 × 109/L, within the typical adult interval.

Corrected reticulocyte count. A low red-cell mass distorts the percentage: in anemia, the same absolute output produces a disproportionately high percentage.

Corrected retic % = reticulocyte % × (patient HCT ÷ 45), with 45% as the average normal hematocrit

Worked example. A hematocrit of 30% with a raw count of 8.0% corrects to 8.0 × (30 ÷ 45) = 5.3%.

Reticulocyte production index. In anemia the marrow releases shift reticulocytes that mature in the blood over 2 to 3 days instead of the usual 1, so the corrected percentage still overstates the true daily output unless divided by the maturation time that matches the hematocrit:

Patient HCT (%)Maturation time (days)
40–451.0
35–391.5
25–342.0
15–242.5
Below 153.0

RPI = corrected reticulocyte % ÷ maturation time

Worked example. The suspected hemolysis specimen with hematocrit 30% and corrected count 5.3% falls in the 25 to 34% band: RPI = 5.3 ÷ 2.0 = 2.65. A value above 3 marks clearly adequate compensation; results between 2 and 3 require clinical context before they are called adequate.

Automated reticulocyte counting. Automated platforms stain residual RNA with a fluorescent or absorbance-based nucleic-acid dye and classify tens of thousands of erythrocytes by optical scatter, fluorescence, or absorbance. Precision improves over the 1,000-cell manual method because counting statistics improve with the square root of the cells examined. Laser forward-scatter and fluorescence systems segregate reticulocytes from mature erythrocytes and then subdivide them into low-, medium-, and high-fluorescence bins; impedance and volume-conductivity systems plot stained-cell volume against light scatter or conductivity instead. Depending on platform, three derived measurements follow:

  • Relative and absolute reticulocyte count, on a far larger sample than the manual method.
  • Immature reticulocyte fraction (IRF), the share of reticulocytes in the medium- and high-fluorescence bins, the least mature cells. It may rise early during marrow recovery, but it is not equivalent to the RPI: a high IRF can coexist with a normal or low absolute count when total production remains inadequate. Hemolytic anemia often raises both the absolute count and the IRF; chronic renal disease with erythropoietin deficiency often lowers both.
  • Reticulocyte hemoglobin content, platform names Chr and RET-He, reports the mean hemoglobin content of reticulocytes. It reflects iron available for hemoglobin synthesis over roughly the preceding 3 to 4 days, against the several-month integration the mature indices represent, and can detect iron-restricted erythropoiesis earlier than MCV and MCH.

Fluids received in hematology, cerebrospinal, serous, synovial, and other effusions, require a total nucleated cell count, a term preferred over white-cell count because tissue and malignant cells may be present, and often an erythrocyte count.1,4 Nucleated cells begin deteriorating within 30 minutes of collection, so counts and cytocentrifuge slides are prepared promptly, with thorough but gentle mixing before every step. Current analyzers with a dedicated body-fluid mode adapt impedance and optical counting to very low concentrations and non-blood cellular composition, extended counting time, no dilution, and flagging for possible malignant cells; each platform’s cleared intended-use statement defines which fluid types it covers.

Manual method, required when no body-fluid mode exists or counts are very low: clear fluid is counted undiluted; hazy or bloody fluid is diluted into a countable range. Erythrocytes dilute in isotonic saline; nucleated cells dilute in a validated acetic-acid reagent or Türk solution, acetic acid with methylene blue, which also stains nuclei while lysing erythrocytes. Concentrated glacial acetic acid is corrosive and is never used undiluted. Acetic acid precipitates synovial-fluid hyaluronic acid, so viscous specimens receive hyaluronidase pretreatment and the laboratory’s validated synovial-fluid diluent and method.

Gross appearanceTypical WBC dilutionTypical RBC dilutionSquares counted
ClearUndilutedUndilutedAll 9, both sides
Hazy1:2 in Türk solutionUndilutedAll 9
Blood-tinged1:2 in Türk solutionUndilutedAll 9, or 4 large
Cloudy1:20 in Türk solutionUndiluted9, or 4 large or 5 small
Grossly bloody1:2 in Türk solution1:200 in saline4 large (WBC) or 5 small (RBC)

The Body Fluid Cell Counts and Cerebrospinal Fluid topic owns the shared counting sequence, chamber selection, and the CSF, synovial, and serous-fluid interpretation built on these counts; the traumatic-tap correction belongs to the appendix.

Cytocentrifuge differential. After the total nucleated cell count, the cytocentrifuge slide is prepared from the mixed specimen over an absorbent filter card; CLSI H56-A, Body Fluid Analysis for Cellular Composition, is the technical reference, with spin speed and time established by the laboratory for its own chamber system.3 Dilute a hypercellular fluid before loading to preserve a readable monolayer. Scant or protein-poor fluid such as cerebrospinal fluid receives one drop of sterile 22% bovine serum albumin in the chamber before the specimen; the albumin coats slide and chamber surfaces, improves cell adherence against the filter card, and limits smudging and lysis of fragile cells during the spin. Stain the air-dried slide with the same Romanowsky stain used on blood films and perform a 100-cell differential along the battlement track described for blood films. When fewer than 100 cells are present, examine every cell and report the actual number of each type. Cells in protein-poor fluid degenerate within about an hour of collection, so process specimens promptly and refrigerate delayed specimens at 2 to 8 °C.

Cells recognized on the body-fluid differential.

  • Count neutrophils, lymphocytes, monocytes, and eosinophils as on a blood film, and interpret them against fluid-specific reference intervals.
  • Plasma cells signal a reactive, immunologic, or infectious process in any fluid.
  • Macrophages are larger and more vacuolated than blood monocytes; classify them by their contents. Erythrophagocytosis and leukophagocytosis mark active phagocytic clearance. Hemosiderin-laden macrophages carry iron pigment that forms only after several days of processing, so their presence confirms hemorrhage that preceded the current collection. Lipid-laden macrophages with refractile fat vacuoles mark chyle, cholesterol effusion, or fat embolism.
  • Mesothelial cells are the native lining cells of pleura, pericardium, and peritoneum. Reactive mesothelial cells enlarge, cluster, and grow prominent nucleoli and irregular borders under inflammatory stress, the classic morphologic mimic of malignancy in serous fluid.
  • Synovial lining cells, type A macrophage-like and type B fibroblast-like synoviocytes, shed into synovial fluid from the joint capsule.
  • Ependymal and choroid plexus cells shed into cerebrospinal fluid, singly or in clusters, often after neurosurgical instrumentation; uniform clusters with bland regular nuclei separate them from a malignant cluster.
  • Assess blasts and other malignant cells, lymphoma cells, leukemic blasts, and metastatic carcinoma cells with the same nuclear-to-cytoplasmic, chromatin, and nucleolar criteria used on blood and marrow smears.
  • The LE cell is a neutrophil that has phagocytized a round homogeneous body of denatured nuclear material, found in lupus erythematosus. The Reiter cell is a vacuolated macrophage that has ingested neutrophils, found in reactive arthritis. The ragocyte, or RA cell, is a neutrophil studded with fine dark granules of precipitated rheumatoid factor and immune complexes, found in rheumatoid arthritis.

Interpretation.

Fluid and settingPredominant cellInterpretation
CSF, bacterial meningitisNeutrophilsAny neutrophils above the laboratory’s upper limit carry significance regardless of the total count; normal adult CSF holds lymphocytes and monocytes only
CSF, viral, tuberculous, or fungal meningitisLymphocytesMononuclear pleocytosis
CSF, parasitic infection or shunt-hardware reactionEosinophilsForeign-material or parasitic response
Synovial fluid, septic or crystal-induced arthritisNeutrophilsInflammatory group II and septic group III patterns
Synovial fluid, noninflammatory diseaseLymphocytes and monocytesMononuclear pattern
Synovial fluid, inflammatory immunologic diseaseNeutrophils often predominateInflammatory pattern
Serous fluid, transudateLymphocytes and mesothelial cellsLow total cell count
Serous fluid, exudateNeutrophils, or malignant or LE-cell formsElevated total cell count

Pitfalls. A traumatic tap contributes peripheral blood cells in blood’s own proportions and raises both the nucleated count and the neutrophil percentage; the bloody-tap correction is applied before a traumatic-tap differential is interpreted. A specimen that clots or clumps before cytocentrifugation can trap or exclude cell types, so slide quality and cell distribution are assessed before counting. Delayed unrefrigerated specimens accumulate pyknotic and karyorrhectic cells whose condensed chromatin mimics blasts. Body-fluid differentials report against the fluid’s own reference interval and never as a peripheral-blood differential.

Point-of-care hematology testing

CLIA assigns complexity to the specific test system, so point-of-care hematology tests may be waived, moderate complexity, or high complexity, and oversight follows that classification under the applicable regulations.4

  • Hematocrit. Microhematocrit centrifugation or conductometric measurement: plasma conducts current while cells act as insulators, so measured conductance, corrected for temperature and plasma electrolyte concentration, converts to hematocrit. Low total protein falsely lowers the result; lipemia and elevated white-cell counts falsely raise it because white cells also insulate; cold agglutinins falsely lower it. These interferences can make a conductometric point-of-care hematocrit disagree with a spun microhematocrit.
  • Hemoglobin. Handheld hemoglobinometers lyse the sample and form azidemethemoglobin, read photometrically at two wavelengths to cancel turbidity, correlating well with the reference cyanmethemoglobin method. The dominant error source is dilution with tissue fluid from a poorly performed skin puncture.
  • Cell and platelet counts. A few point-of-care platforms perform a complete blood count with platelet count, and specialized buffy-coat analyzers spin capillary tubes to expand and fluorescently read the platelet, mononuclear, and granulocyte layers.
References
  1. Keohane EM, Preston MM, Mirza KM, Walenga JM, eds. Rodak's Hematology: Clinical Principles and Applications. 7th ed. Elsevier; 2025. Accessed August 31, 2026.
  2. Clinical and Laboratory Standards Institute. Methods for Reticulocyte Counting (Automated Blood Cell Counters, Flow Cytometry, and Supravital Dyes); Approved Guideline. CLSI document H44-A2. Wayne, PA: CLSI; 2004.
  3. Clinical and Laboratory Standards Institute. Body Fluid Analysis for Cellular Composition; Approved Guideline. CLSI document H56-A. Wayne, PA: CLSI; 2006.
  4. Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments, 42 CFR Part 493. Accessed August 31, 2026.